Secondary Logo

Journal Logo

Articles by Wichittra Tassaneeyakul

Cost-effectiveness analysis of HLA-B*58: 01 genetic testing before initiation of allopurinol therapy to prevent allopurinol-induced Stevens–Johnson syndrome/toxic epidermal necrolysis in a Malaysian population

Chong, Huey Yi; Lim, Yi Heng; Prawjaeng, Juthamas; More

Pharmacogenetics and Genomics. 28(2):56-67, February 2018.

Dapsone-induced severe cutaneous adverse drug reactions are strongly linked with HLA-B*13: 01 allele in the Thai population

Tempark, Therdpong; Satapornpong, Patompong; Rerknimitr, Pawinee; More

Pharmacogenetics and Genomics. 27(12):429-437, December 2017.

Risk factors of allopurinol-induced severe cutaneous adverse reactions in a Thai population

Saksit, Niwat; Tassaneeyakul, Wichittra; Nakkam, Nontaya; More

Pharmacogenetics and Genomics. 27(7):255-263, July 2017.

Associations between HLA class I and cytochrome P450 2C9 genetic polymorphisms and phenytoin-related severe cutaneous adverse reactions in a Thai population

Tassaneeyakul, Wichittra; Prabmeechai, Napat; Sukasem, Chonlaphat; More

Pharmacogenetics and Genomics. 26(5):225-234, May 2016.

Candidate HLA genes for prediction of co-trimoxazole-induced severe cutaneous reactions

Kongpan, Thachanan; Mahasirimongkol, Surakameth; Konyoung, Parinya; More

Pharmacogenetics and Genomics. 25(8):402-411, August 2015.

Strong association between HLA-B*5801 and allopurinol-induced Stevens–Johnson syndrome and toxic epidermal necrolysis in a Thai population

Tassaneeyakul, Wichittra; Jantararoungtong, Thawinee; Chen, Pei; More

Pharmacogenetics and Genomics. 19(9):704-709, September 2009.

Caffeine as a probe for human cytochromes P450: validation using cDNA-expression, immunoinhibition and microsomal kinetic and inhibitor techniques

Tassaneeyakul, Wichittra; Mohamed, Zahurin; Birkett, Donald J.; More

Pharmacogenetics. 2(4):173, August 1992.